Clinical trial Recruiting at 1 site Observational Ages 6 to 12 Men only

Non-helium MEG to look for brain activity patterns in boys with autism

Official title: Non-Helium Magnetoencephalography for Identifying Neurobiological Features and Functional Biomarkers in Children With Autism Spectrum Disorder: An Observational Cohort Study

Run by Guangzhou Women and Children's Medical Center · NCT07064967 · Data updated 2026-11-12

This project will try non-helium MEG scans to see if they can find brain activity patterns that distinguish boys aged 6–12 with autism from typically developing children.

Quick facts

Study typeObservational
Ages6 Years to 12 Years
SexMen only
Enrollment80 (estimated)
SponsorGuangzhou Women and Children's Medical Center
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedNovember 5, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJuly 15, 2025
Trial IDNCT07064967 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Boys aged 6–12 with a DSM-5 diagnosis of autism, IQ >70, able to tolerate MEG, and without major neurological/genetic comorbidities, metallic implants, or current antipsychotic/sedative use.

Probably not a fit

Children with severe developmental disabilities, comorbid neurological or genetic syndromes, metallic implants, or who are taking antipsychotic medications or sedatives are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project uses a non-helium magnetoencephalography (MEG) system to record brain activity in boys aged 6–12 with autism and in typically developing peers. Participants complete MEG recordings during both resting and simple task conditions while researchers analyze neural oscillations and connectivity patterns. Enrollment focuses on children with IQ above 70 who can comply with the procedures and excludes those with major neurological/genetic comorbidities, metallic implants, or current antipsychotic/sedative use. The aim is to identify characteristic MEG features that could support earlier or more accurate ASD diagnosis.

Why it matters

Potential benefit: If successful, this could lead to MEG-based biomarkers that help diagnose autism earlier or more accurately in children.

How similar studies have gone: Previous MEG research has reported differences in neural oscillations and connectivity in autism and shows promise, but has not yet produced definitive diagnostic biomarkers, while non-helium MEG is a newer technical approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Boys aged 6 to 12 years;
* Diagnosis of Autism Spectrum Disorder meeting DSM-5 criteria;
* Intelligence quotient (IQ) score \> 70 (assessed via Wechsler Intelligence Scale for Children or other validated cognitive test);
* Sufficient compliance to participate in MEG experiments.

Exclusion Criteria:

* Comorbid neurological disorders, genetic syndromes, or severe developmental disabilities;
* Metallic implants that may interfere with MEG signal acquisition;
* Current use of antipsychotic medications or sedatives.

Where it's running

  • Guangzhou Women and Children's medical center
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.